CME Group Inc. (CME)
| Market Cap | 92.16B -7.0% |
| Revenue (ttm) | 6.76B +5.1% |
| Net Income | 4.27B +13.8% |
| EPS | 11.79 +14.2% |
| Shares Out | 362.36M |
| PE Ratio | 21.56 |
| Forward PE | 20.46 |
| Dividend | $11.35 (4.46%) |
| Ex-Dividend Date | Jun 9, 2026 |
| Volume | 2,878,194 |
| Open | 250.35 |
| Previous Close | 249.24 |
| Day's Range | 249.74 - 257.53 |
| 52-Week Range | 218.31 - 329.16 |
| Beta | 0.28 |
| Analysts | Buy |
| Price Target | 283.93 (+11.64%) |
| Earnings Date | Jul 22, 2026 |
About CME
CME Group Inc., together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, and foreign exchange; and agricultural, energy, and metals commodities, as well as fixed income and foreign currency trading services. The company provides clearing house services, including clearing, settling, and guaranteeing futures and options contracts, and cleared swaps products traded through its exchanges. In additi... [Read more]
Financial Performance
In 2025, CME Group's revenue was $6.51 billion, an increase of 6.32% compared to the previous year's $6.12 billion. Earnings were $4.02 billion, an increase of 15.50%.
Financial StatementsAnalyst Summary
According to 16 analysts, the average rating for CME stock is "Buy." The 12-month stock price target is $283.93, which is an increase of 11.64% from the latest price.
News
CME Group price target raised to $250 from $249 at JPMorgan
JPMorgan raised the firm’s price target on CME Group (CME) to $250 from $249 and keeps an Underweight rating on the shares. The firm updated the company’s model post the…
CME Group price target raised to $330 from $324 at Morgan Stanley
Morgan Stanley analyst Michael Cyprys raised the firm’s price target on CME Group (CME) to $330 from $324 and keeps an Overweight rating on the shares. CME’s deepening moat and…
CME Group price target raised to $230 from $226 at BofA
BofA analyst Craig Siegenthaler raised the firm’s price target on CME Group (CME) to $230 from $226 and keeps an Underperform rating on the shares after the company reported Q2…
CME profit tops estimates, CEO says 'perps' chatter overshadows results
CME Group beat Wall Street's second-quarter profit estimates on Wednesday, fueled by strong hedging demand, sending the derivatives exchange's shares up 6.1%.
CME Group Earnings Call Transcript: Q2 2026
Record Q2 revenue and strong institutional volumes drove robust financial results, with continued innovation in product offerings such as 24/7 trading and upcoming launches in Single Stock and Compute Futures. Market data revenue and capital efficiencies also reached new highs.
CME Group Earnings release: Q2 2026
CME Group released its Q2 2026 earnings on July 22, 2026, summarizing the period's financial results.
CME Group Slides: Q2 2026
CME Group has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on July 22, 2026.
CME Group reports Q2 adjusted EPS $2.99, consensus $2.91
Reports Q2 revenue $1.71B, consensus $1.68B. “The first half of 2026 was the strongest in CME Group’s (CME) history,” said CME Group Chairman and Chief Executive Officer Terry Duffy. “We…
CME Group reports Q2 ADV 29.8M contracts
Second-quarter 2026 average daily volume was the third highest quarterly ADV reaching 29.8M contracts, which included non-U.S. ADV of 9.1M contracts.
CME Group Inc. Reports Strong Financial Results for Q2 2026
CHICAGO, July 22, 2026 /PRNewswire/ -- CME Group Inc. (NASDAQ: CME) today reported financial results for the second quarter of 2026. The company reported revenue of $1.7 billion and operating income o...
CME Group Launches Sorghum Basis Futures to Meet Global Feed, Export and Biofuel Demand
CHICAGO, July 21, 2026 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today announced plans to launch Sorghum basis futures. Trading is expected to start on August 24, 2026, p...
CME Group price target lowered to $295 from $329 at Piper Sandler
Piper Sandler lowered the firm’s price target on CME Group (CME) to $295 from $329 and keeps an Overweight rating on the shares. The firm updated models in the exchange…
CME Group price target lowered to $324 from $353 at Morgan Stanley
Morgan Stanley lowered the firm’s price target on CME Group (CME) to $324 from $353 and keeps an Overweight rating on the shares. Brokers & Exchanges are expected to deliver…
CFTC to block CME's plan for 24/7 crude oil futures trading
The U.S. Commodity Futures Trading Commission (CFTC) said on Thursday it would exercise its authority to stay the listing of a contract that would have allowed CME Group to initiate 24/7 trading on ...
CME Group price target lowered to $270 from $316 at Barclays
Barclays lowered the firm’s price target on CME Group (CME) to $270 from $316 and keeps an Equal Weight rating on the shares.
CME Group price target lowered to $260 from $310 at UBS
UBS analyst Alex Kramm lowered the firm’s price target on CME Group (CME) to $260 from $310 and keeps a Buy rating on the shares. Estimate revisions are primarily driven…
CME Group reports June ADV of 30.6M contracts
CME Group (CME) reported its average daily volume reached a new June record of 30.6M contracts, up 19% year-over-year. The company also hit its second-highest Q2 volume ever, with 29.8M…
CME Group Reports Record June Average Daily Volume and Second-Highest Q2 Ever
Record June ADV of 30.6 million contracts All-time monthly records for equity index and agricultural products in June Q2 ADV reached 29.8 million contracts CHICAGO, July 2, 2026 /PRNewswire/ -- CME Gr...
These 2 Stocks Will Benefit From Increased Volatility. How to Play Them.
How to profit from rallies while reducing your risk should stocks swoon.
CME Group to launch Single Stock futures on July 27
CME Group (CME)will launch Single Stock futures across more than 50 of the top U.S. stocks on July 27, pending completion of all regulatory review and processes. This new offering…
CME Group to Launch Single Stock Futures on July 27
Offering to include standard- and micro-sized contracts across 50+ leading U.S. stocks Alphabet, Amazon, Apple, Meta, Nvidia and SpaceX among listed firms CHICAGO, June 30, 2026 /PRNewswire/ -- CME Gr...
The Big 3: CME, DASH, CAT
As CME Group (CME) experiences a substantial sell-off dragging shares to 52-week lows, @Theotrade's Don Kaufman sees a "rip your face off" rally occurring once bullish momentum grips the stock. He off...
CME Sues U.S. Regulator to Stop Kalshi From Offering Popular ‘Perp' Futures
The CFTC recently greenlighted Kalshi's plan to list perps in the U.S. CME, the dominant derivatives exchange, argued the regulator violated federal law.
CME CEO Terrence Duffy says the exchange operator will sue CFTC over perpetual futures
Outgoing CME CEO Terrence Duffy said in an appearance on CNBC's “Fast Money” that the exchange operator was planning on suing the Commodity Futures Trading Commission, or CFTC, over perpetual futures....
CME CEO Terry Duffy on suing CFTC: I'm always up for a good battle, 'I won't shy away from this'
Outgoing CME CEO Terry Duffy joins 'Fast Money' to explain why he is planning to sue the CFTC over perpetual futures.